Regulation of the kinin receptors after induction of myocardial infarction: A mini-review

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 6, 2000, Pages 701-708

  Tschope C ^a   Heringer Walther, S ^b   Walther, T ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

B1 receptor; B2 receptor; Bradykinin; Heart infarction; Kallikrein kinin system

Indexed keywords

BRADYKININ RECEPTOR;

ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; HEART INFARCTION; KALLIKREIN KININ SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVIEW;

ANIMALS; KALLIKREIN-KININ SYSTEM; MYOCARDIAL INFARCTION; RATS; RECEPTORS, BRADYKININ;

EID: 0034204472     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000000600011     Document Type: Article

References (48)

1. Tschöpe C, Gohlke P, Zhu Y-Z, Linz W, Schölkens BA & Unger Th (1997). Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins. Journal of Cardiac Failure, 3: 134-148.
2. Nolly H, Carbini LA, Scicli G, Carretero OA & Scicli AG (1994). A local kallikrein-kinin system is present in hearts. Hypertension, 23: 919-923.
3. Chao J, Swain C, Chao S, Xiong W & Chao L (1988). Tissue distribution and kininogen expression after acute-phase inflammation. Biochimica et Biophysics Acta, 964: 329-339.
4. Nagaoka M, Yayama K, Takano M & Okamoto H (1999). Expression of kininogen genes by rat cardiomyocytes. Immunopharmacology, 44: 81-85.
5. Minshall RD, Nakamura F, Becker RP & Rabito SF (1995). Characterisation of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes. Circulation Research, 76: 773-780.
6. Madeddu P, Parpaglia P, Demontis MP, Varoni MV, Fattaccio MC, Anania V & Glorioso N (1995). Early blockade of bradykinin B2-receptors alters the adult cardiovascular phenotype in rats Hypertension, 25: 453-459.
7. Emanueli C, Maestri R, Carradi D, Marchione R, Minasi A, Tozzi MG, Sali MB, Straino S, Capogrossi MC, Olivettti G & Madeddu P (1999). Dilated and failing cardiomyopathy in bradykinin B2 receptor knock out mice. Circulation, 100: 2359-2365.
8. Walsh DA & Fan T-P (1997). Bradykinin as a growth factor. In: Farmer St.G (Editor), The Kinin System. Academic Press, London, 301-314.
9. Marceau F, Hess JF & Bachvarov DR (1998). The B1 receptors for kinins. Pharmacological Reviews, 50: 357-386.
10. Lamontagne D, Nakhostine N, Couture R & Nadeau R (1996). Mechanisms of kinin B1-receptor-induced hypotension in the anaesthetized dog. Journal of Cardiovascular Pharmacology, 28: 645-650.
11. 9-bradykinin increases during E. coli septicemia in the pig. Advances in Experimental Medicine and Biology, 247B: 389-393.
12. Foucart S, Grondin L, Couture R & Nadeau R (1997). Modulation of noradrenaline release by B1 and B2 kinin receptors during metabolic anoxia in the rat isolated atria. Canadian Journal of Physiology and Pharmacology, 75: 639-645.
13. Chahine R, Adam A, Yamaguchi N, Gaspo R, Regolt D & Nadeau R (1993). Protective effects of bradykinin on the ischemic heart: implication of the B1 receptor. British Journal of Pharmacology, 108: 318-322.
14. Bouchard JF, Chouinard J & Lamontagne D (1998). Role of kinins in the endothelial protective effect of ischemic preconditoning. British Journal of Pharmacology, 123: 413-420.
15. Regoli D & Barabé J (1980) Pharmacology of bradykinin and related Kinins. Pharmacological Reviews, 55: 866-867.
16. Hess JF, Borkowski JA, Young GS, Strader CD & Ransom RW (1992). Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochemical and Biophysical Research Communications, 184: 260-268.
17. Austin KE, Faussner A, Robinson HE, Chakravarty S, Kyle DJ, Bathon JM & Proud D (1997). Stable expression of the kinin B1 receptor in Chinese hamster ovary cells. Journal of Biological Chemistry, 271 11420-11425.
18. Faussner A, Bathon JM & Proud D (1999). Comparison of the responses of B1 and B2 kinin receptors to agonist stimulation. Immunopharmacology, 45: 13-20.
19. Linz W, Wiemer G, Gohlke P, Unger Th & Schölkens BA (1995). Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacological Reviews, 47: 25-50.
20. Praddaude F, Tack I, Emond C, Bascands JL, Girolami JP, Tran-Van T, Regoli D & Ader JL (1995). In vivo and in vitro homologous desensitization of rat glomerular bradykinin B2 receptors. European Journal of Pharmacology, 294: 173-182.
21. Blaukat A, AbdAlla S, Lohse MJ & Müller-Esterl W (1996). Ligand-induced phosphorylation/dephosphorylation of the endogenous bradykinin B2 receptor from human fibroblasts. Journal of Biological Chemistry, 271: 32366-32374.
22. Ni A, Chao L & Chao J (1998). Transcription factor nuclear factor KB regulates the inducible expression of the human B1 receptor gene in inflammation. Journal of Biological Chemistry, 273: 2784-2791.
23. 10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulalion of the bradykinin B1-receptor in cultured human lung fibroblasts. Journal of Clinical Investigation, 101: 2080-2091.
24. Lochner W & Parratt JR (1966). A comparison of the effects of locally and systematically administrated kinins on coronary blood flow and myocardial metabolism. British Journal of Pharmacology, 26: 17-26.
25. Kimura E, Hashimoto K & Furakawa H (1973). Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. American Heart Journal, 85: 635-647.
26. Hashimoto K, Hirose M, Furukawa K, Hayakawa H & Kimura E (1977). Changes in hemodynamic and bradykinin concentration in coronary sinus blood in experimental coronary artery occlusion. Japanese Heart Journal, 18: 679-680.
27. Baumgarten CR, Linz W, Kunke G, Schölkens BA & Wiemer G (1993). Ramiprilat increases bradykinin outflow from isolated rat hearts. British Journal of Pharmacology, 108: 293-295.
28. 9-bradykinin release following reperfusion of the ischemic rat heart. British Journal of Pharmacology, 115: 476-478.
29. Hashimoto K, Hamamoto H, Honda Y, Hirose M, Furukawa S & Kimura E (1978). Changes in components of kinin system and hemodynamic in acute myocardial infarct American Heart Journal, 95: 619-626.
30. Rösen P, Rösen R, Hohl C, Reinauer H & Klaus W (1984). Reduced transcoronary exchange and prostaglandin synthesis in diabetic rat heart. American Journal of Physiology, 247: H563-H569.
31. Weber KT, Sun Y, Katwa LC & Cleutjens JPM (1995). Connective tissue: a metabolic entity? Journal of Molecular and Cellular Cardiology, 27: 107-120.
32. Marceau F, Larrivee J-F, Bouthillier J, Bachvarova M, Hule S & Bachvarov DR (1999). Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit. American Journal of Physiology, 277: R1568-R1578
33. Tschöpe C, Heringer-Walther S, Koch M, Spillmann F, Wendorf M, Hauke D, Bader M, Schultheiss H-P & Walther T (2000). Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction. Journal of Hypertension (in press).
34. Tschöpe C, Koch M, Spillmann F, Heringer-Walther S, Mochmann H-Ch, Stauss H, Bader M, UngerTh, Schultheiss H-P & Walther T (1999). Upregulation of the cardiac bradykinin B2 receptor after myocardial infarction. Immunopharmacology, 44: 111-117.
35. Tschöpe C, Heringer-Walther S, Koch M, Spillmann F, Wendorf M, Leitner E, Schultheiss H-P & Walther T (2000). Up-regulation of bradykinin B1-receptor expression after myocardial infarction. British Journal of Pharmacology (in press).
36. Yue P, Massie BM, Simpson PC & Long CS (1998). Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. American Journal of Physiology, 44: H250-H258.
37. Zhou X, Polgar P & Taylor L (1998). Roles for interleukin-1ß, phorbol ester and a post-transcriptional regulator in the control of bradykinin B1 receptor gene expression. Biochemical Journal, 330: 361-366.
38. Faussner A, Heinz-Erian P, Klier C & Roscher AA (1991). Solubilization and characterization of B2 bradykinin receptors from cultured human fibroblasts. Journal of Biological Chemistry, 266: 9442-9446.
39. Tiffany CW & Burch RM (1989). Bradykinin stimulates tumor necrosis factor and interleukin 1ß release from macrophages. FEBS Letters, 247: 189-192.
40. Pan ZK, Zuraw BL, Lung C-C, Prossnitz ER, Browning DD & Ye RD (1996). Bradykinin stimulates NF-kB activation and interleukin 1ß gene expression in cultured human fibroblasts. Journal of Clinical Investigation, 98: 2042-2049.
41. 9-bradykinin, on rat croton oil-induced granulation tissue contraction. British Journal of Pharmacology, 111: 290P (Abstract).
42. Morbidelli L, Parenti A, Giovannelli L, Granger HJ, Ledda F & Ziche M (1998). B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. British Journal of Pharmacology, 124: 1286-1292.
43. Sun Y, Diaz-Arias AA & Weber KT (1994). Angiotensin-converting enzyme, bradykinin and angiotensin II receptor binding in rat skin, tendon and heart valves: an in vitro quantitative autoradiographic study. Journal of Laboratory and Clinical Medicine, 123: 372-377.
44. Kim NN, Villegas S, Summerour SR & Villarreal FJ (1999). Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. Journal of Molecular and Cellular Cardiology, 31: 457-466.
45. Martorana PA, Kettenbach B, Breipohl G, Linz W & Schölkens BA (1990). Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. European Journal of Pharmacology, 182: 395-396.
46. Stauss HM, Zhu YC, Redlich T, Adamiak D, Mott A, Kregel K & Unger T (1994). ACE inhibitors in infarct induced heart failure: bradykinin versus angiotensin II. Journal of Cardiovascular Risk, 1: 255-262.
47. McDonald KM, Carlyle PF, Mathews J, Hauer K, Elbers T, Hunter D & Cohn JN (1990). Early ventricular remodelling after myocardial damage and its attenuation by converting enzyme inhibition. Transactions of the Association of American Physicians, 103: 229-235.
48. Hu K, Goudron P, Anders H-J, Weidemann F, Turschner O, Nahrendorf M & Ertl G (1998). Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. Cardiovascular Research, 39: 401-412.